Home » Healthcare » Respiratory Inhaler Devices Market

Respiratory Inhaler Devices Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler, Others) By Patient (Adult, Paediatric)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 19695 | Report Format : PDF

Market Insights

  • The global demand for respiratory inhaler devices was valued at USD 35.2 billion in 2022 and is expected to reach USD 50.19 Billion in 2030, growing at a CAGR of 5.20% between 2023 and 2030.
  • Metered dose inhalers are the leading segment in the product type and held largest of the share in terms of value in 2022
  • The dry powder inhaler segment will likely exhibit the fastest CAGR during the forecast period.
  • Adult patients hold the largest market share among the patient segment.
  • Digitally operated device holds the largest revenue share in 2022 among the technology.
  • Chronic obstructive pulmonary diseases (COPD) hold the largest revenue share in 2022 among the disease indication segment.
  • Asthma is expected to post the highest CAGR during the forecast period among the end-use industry
  • Hospitals were the largest end users of respiratory inhaler devices and held the largest market share, with more than 35% share in 2022.
  • Whereas pharmaceuticals hold the fastest growing CAGR over the forecast period.
  • North America is fuelling the growth of the Respiratory Inhaler Devices industry with nearly a two-fifth share in 2022, while Europe and Asia-pacific collectively accounted for just nearly under 55% share in 2022. Asia-pacific held over 22% share in 2022.
  • The respiratory inhaler device market is driven by factors such as the growing prevalence of respiratory disorders, technological advancements in inhaler device design, growing awareness about respiratory health, and the need for convenient and effective treatment options. Various manufacturers, including pharmaceutical companies, medical device companies, and specialized inhaler manufacturers, characterize the market.

Respiratory Inhaler Devices Market

Key Highlights of the Report

The global respiratory inhaler devices market is segmented by packaging product type, patient, technology, disease indication, end user, and region. Metered dose inhalers hold the largest market share among the product type segment, and adults dominate the patient segment, with digitally operated devices being the largest technology segment. Chronic obstructive pulmonary disorder (COPD) was the largest disease indication segment, and hospitals were the largest end users of respiratory inhaler devices, with North America leading the market growth.

The global respiratory inhaler devices market has been driven by the increased incidence of respiratory disorders across the globe. Additionally, the increasing emergence of smart inhaler devices drives market growth. However, the market also faces significant challenges, including increasing adoption of alternative therapies such as oral medication or subcutaneous injections, restrain the market’s overall growth.

Nonetheless, the global respiratory inhaler devices market offers significant growth opportunities, such as the increasing adoption of combination therapies for asthma. The development of such specialized inhaler devices supports the administration of combination therapies, catering to the specific needs of patients and healthcare providers. Technological advancements in inhaler devices further drive the growth of the respiratory inhaler market.

Market Overview

The global respiratory inhaler devices market has witnessed steady growth in recent years and is expected to grow at a CAGR of 17.50% between 2023 and 2030. The market was valued at USD 4.5 billion in 2022 and is expected to reach USD 13.91 billion in 2030.

What Are the Main Drivers of The Global Respiratory Inhaler Devices Market?

Several factors, including Rising Prevalence of respiratory disorders, drive the global respiratory inhaler devices market.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

What Are the Major Challenges the Global Respiratory Inhaler Devices Market Faces?

The global respiratory inhaler devices market also faces challenges like Increasing adoption of alternative therapies such as oral medication or subcutaneous injections.

What Are the Growth Opportunities in The Global Respiratory Inhaler Devices Market?

The global respiratory inhaler devices market offers significant growth opportunities, such as the increasing adoption of combination therapies for asthma.

Respiratory Inhaler Devices Market

Executive Summary

Overview of the Global Respiratory Inhaler Devices Market

The global respiratory inhaler devices market has grown steadily in recent years. These inhaler devices are primarily used for treating various respiratory disorders such as asthma, COPD, bronchitis, and other respiratory conditions. The increasing emergence of smart inhaler devices will drive global market growth over the forecast period.

Market Definition

The respiratory inhaler, a puffer, spray, or pump, is a medical device designed to deliver medication directly into the body through the lungs. It is primarily used for treating respiratory diseases such as asthma, bronchitis, allergic rhinitis, Chronic Obstructive Pulmonary Disorder (COPD), pneumonia, and sinusitis. These conditions can significantly impede an individual’s physical activities. The category of orally inhaled and nasal drug products (OINDPs) encompasses various inhaler types, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), nasal sprays, and nebulizers.

Segmentation by Product Type

  • Metered dose inhalers were the leading segment and largest share in value in 2022.
  • The dry powder inhaler will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Patient

  • Adults were the leading segment and largest share in value in 2022 and are expected to hold the fastest-growing CAGR over the forecast period.

Segmentation by Technology

  • Digitally operated devices were the leading segment and largest share in value in 2022 and are likely to exhibit the fastest CAGR during the forecast period.

Segmentation by Disease Indication

  • Chronic obstructive pulmonary disease was the leading segment and largest share in value in 2022.
  • Asthma will likely exhibit the fastest CAGR during the forecast period.

Segmentation by End User

  • Hospitals were the largest end-user of respiratory inhaler devices across the globe
  • Pharmaceuticals are expected to put the fastest growing CAGR over the forecast period

Segmentation by Region

  • North America was fuelling the growth of the Respiratory Inhaler Devices industry with a nearly two-fifths share in 2022.
  • Asia Pacific and Europe collectively account for nearly under 55% share in 2022, with Europe holding over 22% share in the same year.
  • The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for Respiratory Inhaler Devices.

Advancements in technology have played a significant role in developing smart inhaler devices. These devices have sensors, Bluetooth connectivity, and smartphone applications, enabling seamless data collection and analysis. The integration of digital health technologies and the Internet of Things (IoT) in respiratory care has expanded the capabilities of inhaler devices and driven market growth. Patients and healthcare providers increasingly embrace the convenience and benefits of connected inhaler devices, fostering market expansion.

In the U.S., increasing adoption of inhalers across the country is expected to drive market growth over the forecast period. For instance, according to the National Institute of Biotechnology Information report in February 2021, Medicare Part D provided inhalers to approximately 85 million beneficiaries. The total expenditure on these prescriptions reached 50.5 billion US dollars, indicating a significant increase of 130% in users and 128% in expenditure over the same period. The expenses incurred by Medicare for inhaler prescriptions are on an upward trajectory and are projected to continue increasing in the foreseeable future.

In China, increasing healthcare expenditure across the country’s population is expected to drive market growth over the forecast period. For instance, in January 2021, China witnessed a significant increase in public health fiscal expenditure in 2020 to combat COVID-19. This occurred despite a decrease in fiscal revenue compared to the previous year. Although the central government has been urging both central and local authorities to exercise fiscal restraint by reducing general spending, there was a notable increase in funding allocated to critical areas. Specifically, total expenditure on public health rose by 15.2 percent, reaching 1.9 trillion yuan (approximately $293 billion) compared to the previous year.

The respiratory inhaler device market is global, with demand and sales spanning various regions and countries. Market trends and growth vary depending on factors such as the prevalence of respiratory disorders, healthcare infrastructure, reimbursement policies, and patient preferences. Overall, the respiratory inhaler device market is vital in providing effective and convenient treatment options for individuals with respiratory disorders, improving their quality of life and respiratory health.

Rising Prevalence of Respiratory Disorders

Respiratory disorders have become a significant global health concern due to several factors, including urbanization, environmental pollution, lifestyle changes, and an aging population. These conditions significantly burden healthcare systems worldwide, leading to increased hospitalizations, healthcare costs, and reduced quality of life for affected individuals. As a result, there is a pressing need for effective and accessible treatment options, spurring the demand for respiratory inhaler devices.

Improved awareness about respiratory disorders and advancements in diagnostic techniques have contributed to the increased detection and diagnosis of these conditions. With greater awareness among both patients and healthcare professionals, more individuals are being identified as having respiratory disorders at an early stage. Early diagnosis allows for timely intervention and management, where inhaler devices are crucial in delivering medication directly to the lungs, providing relief and improving overall respiratory health. For instance, according to the data published by the National Institute of Biotechnology Research, As of 2017, it was estimated that approximately 544.9 million individuals worldwide were affected by chronic respiratory diseases, representing a 39.8% increase compared to the number of individuals affected in 1990 (389.7 million). The global prevalence in 2017 was approximately 7.1%.

The Increasing Emergence of Smart Inhaler Devices

Smart inhaler devices address this issue by offering features that promote adherence, such as reminders and notifications for medication dosing. These devices can track and record inhaler usage, helping patients monitor their adherence and follow prescribed treatment plans more effectively. Improved medication adherence leads to better symptom control and reduces the risk of exacerbations, driving the demand for smart inhaler devices. Smart inhaler devices enable real-time monitoring of inhaler usage and provide feedback to patients and healthcare providers. These devices collect data on inhaler technique, frequency of use, and environmental factors affecting respiratory health. With the help of connected apps or cloud-based platforms, patients can receive personalized feedback, insights, and recommendations to optimize their treatment. Healthcare providers can access this data remotely, allowing for proactive interventions and individualized care. The ability to monitor and track respiratory health in real-time is a significant driver for adopting smart inhaler devices.

Increasing Adoption of Alternative Therapies Such as Oral Medication or Subcutaneous Injections

While inhaler devices have been proven to be highly effective in delivering medication directly to the lungs, there is a perception among some patients and healthcare providers that alternative therapies may be equally effective or even superior. Various factors, including marketing strategies, patient experiences, and clinical trials comparing treatment modalities, can influence this perception. Such perceptions can lead to a shift towards alternative therapies, reducing the demand for respiratory inhaler devices and restraining market growth. The availability of generic oral medications for respiratory conditions has increased in recent years. Generic drugs are often more affordable and accessible to patients, leading to a higher adoption rate compared to inhaler devices that may have brand-specific formulations and higher costs. The cost-effectiveness of oral medications makes them an attractive choice for patients and healthcare providers, hindering the growth of the respiratory inhaler devices market.

The Increasing Adoption of Combination Therapies for Asthma

Combination therapies for asthma typically involve administering different classes of medications, such as bronchodilators and corticosteroids, through a single inhaler device. This approach allows for a synergistic effect, targeting asthma’s underlying inflammation and bronchial constriction. By combining medications with complementary mechanisms of action, combination therapies offer improved treatment efficacy, better symptom control, and reduced risk of exacerbations. The superior therapeutic outcomes associated with combination therapies contribute to their growing adoption and drive the demand for respiratory inhaler devices.

Competitive Landscape

Key Players

The global respiratory inhaler devices market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

These companies focus on product innovation, expanding their applications, mergers, and acquisitions to stay ahead.

The major players in the global respiratory inhaler devices market constantly strive to stay ahead by introducing new products and innovations.

In February 2022, Aptar Pharma, a leading global provider of drug delivery systems, introduced HeroTracker Sense, a groundbreaking digital respiratory health solution. HeroTracker Sense transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device. It aims to enhance the lives of patients worldwide with chronic respiratory diseases like asthma, COPD, Cystic Fibrosis, and those caused by COVID-19. By monitoring MDI usage and promoting adherence, HeroTracker Sense addresses inhalation techniques and encourages patients to follow their prescribed therapy.

In October 2022,  AirPhysio, an Australia-based company, officially launched its range of respiratory devices in the city. Former Australian cricketer Brett Lee graced the product launch event, and Suneeta Reddy, the managing director of Apollo Hospitals, was also in attendance. AirPhysio, in collaboration with Medsmart and Apollo Group, aims to introduce its respiratory devices nationwide. The global CEO of AirPhysio and Better Breathing Group, Paul O’Brien, mentioned the remarkable expansion of AirPhysio from just two countries in January 2020 to now serving over 106 countries worldwide.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • Rising Prevalence of respiratory disorders across the globe is driving the demand for respiratory inhaler devices.
  • Market segmented by product type, patient, technology, disease indication, end user, and region.
  • Metered dose inhalers are the most popular product type holding the largest market share during the forecast period.
  • Dry power inhaler holds the fastest growing CAGR among the product type over the forecast period.
  • Adult patients held the highest market share in 2022.
  • Digitally operated devices held the dominant market share in 2022, the fastest-growing segment across the technology.
  • Chronic obstructive pulmonary disease (COPD) holds the largest market share in the disease indication segment.
  • Hospitals hold the dominant market share in terms of value at the end-user segment
  • North America is leading market growth; the market is highly competitive with key players, including GlaxoSmithKline plc, Propeller Health, Merck & Co., Inc., Cohero Health, Inc., and others.

Future Outlook

  • Positive outlook for the global respiratory inhaler devices market with significant growth potential in the North American region
  • The increasing emergence of smart inhaler devices will drive market growth.
  • Challenges like the increasing adoption of alternative therapies such as oral medication or subcutaneous injections are expected to hamper the overall global market growth over the forecast period.

Segmentation

  • By Product Type
    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Soft Mist Inhaler
    • Others
  • By Patient
    • Adult
    • Paediatric
  • By Technology
    • Manually Operated Devices
    • Digitally Operated Device
  • By Disease Indication
  • By End User
    • Hospitals
    • Clinics
    • Pharmaceuticals
    • Respiratory Care Centers
    • Others
  • By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Respiratory Inhaler Devices Market
2.2. Global Respiratory Inhaler Devices Market, By Product Type
2.3. Global Respiratory Inhaler Devices Market, By Patient
2.4. Global Respiratory Inhaler Devices Market, By Technology
2.5. Global Respiratory Inhaler Devices Market, By Disease Indication
2.6. Global Respiratory Inhaler Devices Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Respiratory Inhaler Devices Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Patient
3.5.3. Technology
3.5.4. Disease Indication
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Product Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Soft Mist Inhaler

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Respiratory Inhaler Devices Market, By Product Type
7.1. Global Respiratory Inhaler Devices Market Overview, by Product Type
7.1.1. Global Respiratory Inhaler Devices Market Revenue Share, By Product Type, 2022 Vs 2030 (in %)
7.2. Dry Powder Inhaler
7.2.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
7.3. Metered Dose Inhaler
7.3.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
7.4. Soft Mist Inhaler
7.4.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
7.5. Others
7.5.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)

8. Global Respiratory Inhaler Devices Market, By Patient
8.1. Global Respiratory Inhaler Devices Market Overview, by Patient
8.1.1. Global Respiratory Inhaler Devices Market Revenue Share, By Patient, 2022 Vs 2030 (in %)
8.2. Adult
8.2.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
8.3. Paediatric
8.3.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)

9. Global Respiratory Inhaler Devices Market, By Technology
9.1. Global Respiratory Inhaler Devices Market Overview, by Technology
9.1.1. Global Respiratory Inhaler Devices Market Revenue Share, By Technology, 2022 Vs 2030 (in %)
9.2. Asthma
9.2.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
9.3. Chronic Obstructive Pulmonary Disease (COPD)
9.3.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
9.4. Pulmonary Arterial Hypertension
9.4.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
9.5. Others
9.5.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)

10. Global Respiratory Inhaler Devices Market, By Disease Indication
10.1. Global Respiratory Inhaler Devices Market Overview, by Disease Indication
10.1.1. Global Respiratory Inhaler Devices Market, By Disease Indication, 2022 vs 2030 (in %)
10.2. Hospitals
10.2.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
10.3. Clinics
10.3.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
10.4. Pharmaceuticals
10.4.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
10.5. Respiratory Care Centers
10.5.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)
10.6. Others
10.6.1. Global Respiratory Inhaler Devices Market, By Region, 2017-2030 (US$ Bn)

11. Global Respiratory Inhaler Devices Market, By Region
11.1. Global Respiratory Inhaler Devices Market Overview, by Region
11.1.1. Global Respiratory Inhaler Devices Market, By Region, 2022 vs 2030 (in%)
11.2. Product Type
11.2.1. Global Respiratory Inhaler Devices Market, By Product Type, 2017-2030 (US$ Bn)
11.3. Patient
11.3.1. Global Respiratory Inhaler Devices Market, By Patient, 2017-2030 (US$ Bn)
11.4. Technology
11.4.1. Global Respiratory Inhaler Devices Market, By Technology, 2017-2030 (US$ Bn)
11.5. Disease Indication
11.5.1. Global Respiratory Inhaler Devices Market, By Disease Indication, 2017-2030 (US$ Bn)

12. North America Respiratory Inhaler Devices Market Analysis
12.1. North America Respiratory Inhaler Devices Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Respiratory Inhaler Devices Market, by Patient, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Respiratory Inhaler Devices Market, by Technology, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Respiratory Inhaler Devices Market, by Disease Indication, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Respiratory Inhaler Devices Market, by Country, 2017-2030 (US$ Bn)
12.5.1. North America Respiratory Inhaler Devices Market, by Country, 2022 Vs 2030 (in%)
12.5.2. U.S.
12.5.2.1. U.S. Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. U.S. Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
12.5.2.3. U.S. Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
12.5.2.4. U.S. Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
12.5.2.5. U.S. Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
12.5.3. Canada
12.5.3.1. Canada Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Canada Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
12.5.3.3. Canada Respiratory Inhaler Devices, By Patient Type, 2017-2030 (US$ Bn)
12.5.3.4. Canada Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
12.5.3.5. Canada Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
12.5.4. Mexico
12.5.4.1. Mexico Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.4.2. Mexico Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
12.5.4.3. Mexico Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
12.5.4.4. Mexico Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
12.5.4.5. Mexico Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)

13. Europe Respiratory Inhaler Devices Market Analysis
13.1. Europe Respiratory Inhaler Devices Market, by Product Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Respiratory Inhaler Devices Market, by Patient, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Respiratory Inhaler Devices Market, by Technology, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Respiratory Inhaler Devices Market, by Disease Indication, 2017-2030(US$ Bn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Respiratory Inhaler Devices Market, by Country, 2017-2030 (US$ Bn)
13.5.1. Europe Respiratory Inhaler Devices Market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.2.2. Germany Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.2.3. Germany Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.2.4. Germany Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.2.5. Germany Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
13.5.3. France
13.5.3.1. France Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.3.2. France Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.3.3. France Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.3.4. France Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.3.5. France Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
13.5.4. UK
13.5.4.1. UK Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.4.2. UK Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.4.3. UK Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.4.4. UK Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.4.5. UK Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
13.5.5. Italy
13.5.5.1. Italy Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.5.2. Italy Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.5.3. Italy Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.5.4. Italy Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.5.5. Italy Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
13.5.6. Spain
13.5.6.1. Spain Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.6.2. Spain Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.6.3. Spain Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.6.4. Spain Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.6.5. Spain Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
13.5.7. Rest of Europe
13.5.7.1. Rest of Europe Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.7.2. Rest of Europe Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
13.5.7.3. Rest of Europe Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
13.5.7.4. Rest of Europe Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
13.5.7.5. Rest of Europe Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)

14. Asia Pacific Respiratory Inhaler Devices Market Analysis
14.1. Asia Pacific Respiratory Inhaler Devices Market, by Product Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Respiratory Inhaler Devices Market, by Technology, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Respiratory Inhaler Devices Market, by Disease Indication, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Respiratory Inhaler Devices Market, by Country, 2017-2030 (US$ Bn)
14.5.1. Asia Pacific Respiratory Inhaler Devices Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.2.2. China Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.2.3. China Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.2.4. China Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.2.5. China Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
14.5.3. Japan
14.5.3.1. Japan Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.3.2. Japan Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.3.3. Japan Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.3.4. Japan Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.3.5. Japan Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
14.5.4. India
14.5.4.1. India Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.4.2. India Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.4.3. India Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.4.4. India Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.4.5. India Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
14.5.5. South Korea
14.5.5.1. South Korea Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.5.2. South Korea Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.5.3. South Korea Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.5.4. South Korea Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.5.5. South Korea Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.6.2. South-East Asia Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.6.3. South-East Asia Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.6.4. South-East Asia Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.6.5. South-East Asia Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.7.2. Rest of Asia Pacific Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
14.5.7.3. Rest of Asia Pacific Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
14.5.7.4. Rest of Asia Pacific Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
14.5.7.5. Rest of Asia Pacific Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)

15. Latin America Respiratory Inhaler Devices Market Analysis
15.1. Latin America Respiratory Inhaler Devices Market, by Product Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Respiratory Inhaler Devices Market, by Patient, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Respiratory Inhaler Devices Market, by Technology, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Respiratory Inhaler Devices Market, by Disease Indication, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Respiratory Inhaler Devices Market, by Country, 2017-2030 (US$ Bn)
15.5.1. Latin America Respiratory Inhaler Devices Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.2.2. Brazil Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
15.5.2.3. Brazil Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
15.5.2.4. Brazil Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
15.5.2.5. Brazil Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
15.5.3. Argentina
15.5.3.1. Argentina Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.3.2. Argentina Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
15.5.3.3. Argentina Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
15.5.3.4. Argentina Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
15.5.3.5. Argentina Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.4.2. Rest of Latin America Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
15.5.4.3. Rest of Latin America Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
15.5.4.4. Rest of Latin America Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
15.5.4.5. Rest of Latin America Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)

16. Middle East and Africa Respiratory Inhaler Devices Market Analysis
16.1. Middle East and Africa Respiratory Inhaler Devices Market, by Product Type, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Respiratory Inhaler Devices Market, by Patient, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Respiratory Inhaler Devices Market, by Technology, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Respiratory Inhaler Devices Market, by Disease Indication, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Respiratory Inhaler Devices Market, by Country, 2017-2030 (US$ Bn)
16.5.1. Middle East and Africa Respiratory Inhaler Devices Market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.2.2. GCC Countries Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
16.5.2.3. GCC Countries Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
16.5.2.4. GCC Countries Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
16.5.2.5. GCC Countries Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
16.5.3. South Africa
16.5.3.1. South Africa Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.3.2. South Africa Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
16.5.3.3. South Africa Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
16.5.3.4. South Africa Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
16.5.3.5. South Africa Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Respiratory Inhaler Devices Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.4.2. Rest of Middle East and Africa Respiratory Inhaler Devices, By Product Type, 2017-2030 (US$ Bn)
16.5.4.3. Rest of Middle East and Africa Respiratory Inhaler Devices, By Patient, 2017-2030 (US$ Bn)
16.5.4.4. Rest of Middle East and Africa Respiratory Inhaler Devices, By Technology, 2017-2030 (US$ Bn)
16.5.4.5. Rest of Middle East and Africa Respiratory Inhaler Devices, By Disease Indication, 2017-2030 (US$ Bn)

17. Company Profiles
17.1. Adherium
17.1.1. Company Overview
17.1.2. Product /Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. AstraZeneca
17.3. Boehringer Ingelheim International GmbH
17.4. CHIESI Farmaceutici S.p.A.
17.5. GlaxoSmithKline plc
17.6. Propeller Health
17.7. Teva Pharmaceutical Industries Ltd.
17.8. Beximco Pharmaceuticals Ltd.
17.9. 3M
17.10. Cipla Inc.
17.11. Koninklijke Philips N.V.
17.12. Merck & Co., Inc.
17.13. Omron Healthcare, Inc.
17.14. Cohero Health, Inc.
17.15. PARI GmbH
17.16. Glenmark Pharmaceuticals Limited
17.17. Senzer Ltd
17.18. Novartis AG
17.19. HELTMAN Medikal A.S
17.20. Mundipharma International

List of Figures
FIG. 1 Global Respiratory Inhaler Devices Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Respiratory Inhaler Devices Market Segmentation
FIG. 4 Global Respiratory Inhaler Devices Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Respiratory Inhaler Devices Market, by Patient, 2022 (US$ Bn)
FIG. 6 Global Respiratory Inhaler Devices Market, by Technology, 2022 (US$ Bn)
FIG. 7 Global Respiratory Inhaler Devices Market, by Disease Indication, 2022 (US$ Bn)
FIG. 8 Global Respiratory Inhaler Devices Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Product Type, 2022
FIG. 10 Attractive Investment Proposition, by Patient, 2022
FIG. 11 Attractive Investment Proposition, by Technology, 2022
FIG. 12 Attractive Investment Proposition, by Disease Indication, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Respiratory Inhaler Devices Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Respiratory Inhaler Devices Market Manufacturers, 2022
FIG. 16 Global Respiratory Inhaler Devices Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 17 Global Respiratory Inhaler Devices Market, by Dry Powder Inhaler, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Respiratory Inhaler Devices Market, by Metered Dose Inhaler, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Respiratory Inhaler Devices Market, by Soft Mist Inhaler, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Respiratory Inhaler Devices Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Respiratory Inhaler Devices Market Value Contribution, By Patient, 2022 & 2030 (Value %)
FIG. 22 Global Respiratory Inhaler Devices Market, by Adult, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Respiratory Inhaler Devices Market, by Pediatric, Value, 2017-2030 (US$ Bn)
FIG. 24 Global Respiratory Inhaler Devices Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 25 Global Respiratory Inhaler Devices Market, by Asthma, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Respiratory Inhaler Devices Market, by Chronic Obstructive Pulmonary Disease (COPD), Value, 2017-2030 (US$ Bn)
FIG. 27 Global Respiratory Inhaler Devices Market, by Pulmonary Arterial Hypertension, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Respiratory Inhaler Devices Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Respiratory Inhaler Devices Market Value Contribution, By Disease Indication, 2022 & 2030 (Value %)
FIG. 30 Global Respiratory Inhaler Devices Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Respiratory Inhaler Devices Market, by Clinics, 2017-2030 (US$ Bn)
FIG. 32 Global Respiratory Inhaler Devices Market, by Pharmaceuticals, Value, 2017-2030 (US$ Bn)
FIG. 33 Global Respiratory Inhaler Devices Market, by Respiratory Care Centers, 2017-2030 (US$ Bn)
FIG. 34 Global Respiratory Inhaler Devices Market, by Others, 2017-2030 (US$ Bn)
FIG. 35 North America Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 36 U.S. Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 37 Canada Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 38 Europe Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 39 Germany Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 40 France Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 41 U.K. Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 42 Italy Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 43 Spain Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 44 Rest of Europe Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 45 Asia Pacific Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 46 China Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 47 Japan Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 48 India Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 49 South Korea Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 50 South-East Asia Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 51 Rest of Asia Pacific Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 52 Latin America Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 53 Brazil Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 54 Mexico Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 55 Rest of Latin America Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 56 Middle East & Africa Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 57 GCC Countries Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 58 South Africa Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)
FIG. 59 Rest of Middle East and Africa Respiratory Inhaler Devices Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Respiratory Inhaler Devices Market
TABLE 2 Global Respiratory Inhaler Devices Market: Market Drivers Impact Analysis
TABLE 3 Global Respiratory Inhaler Devices Market: Market Restraints Impact Analysis
TABLE 4 Global Respiratory Inhaler Devices Market, by Competitive Benchmarking, 2022
TABLE 5 Global Respiratory Inhaler Devices Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Respiratory Inhaler Devices Market, by Key Strategies Analysis, 2022
TABLE 7 Global Respiratory Inhaler Devices Market, by Dry Powder Inhaler, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Respiratory Inhaler Devices Market, by Dry Powder Inhaler, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Respiratory Inhaler Devices Market, by Metered Dose Inhaler, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Respiratory Inhaler Devices Market, by Metered Dose Inhaler, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Respiratory Inhaler Devices Market, by Soft Mist Inhaler, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Respiratory Inhaler Devices Market, by Soft Mist Inhaler, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Respiratory Inhaler Devices Market, by other, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Respiratory Inhaler Devices Market, by other, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Respiratory Inhaler Devices Market, by Adult, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Respiratory Inhaler Devices Market, by Adult, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Respiratory Inhaler Devices Market, by Pediatric, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Respiratory Inhaler Devices Market, by Pediatric, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Respiratory Inhaler Devices Market, by Asthma, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Respiratory Inhaler Devices Market, by Asthma, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Respiratory Inhaler Devices Market, by Chronic Obstructive Pulmonary Disease (COPD), By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Respiratory Inhaler Devices Market, by Chronic Obstructive Pulmonary Disease (COPD), By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Respiratory Inhaler Devices Market, by Pulmonary Arterial Hypertension, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Respiratory Inhaler Devices Market, by Pulmonary Arterial Hypertension, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Respiratory Inhaler Devices Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Respiratory Inhaler Devices Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Respiratory Inhaler Devices Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Respiratory Inhaler Devices Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Respiratory Inhaler Devices Market, by Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Respiratory Inhaler Devices Market, by Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Respiratory Inhaler Devices Market, by Pharmaceuticals, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Respiratory Inhaler Devices Market, by Pharmaceuticals, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Respiratory Inhaler Devices Market, by Respiratory Care Centers, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Respiratory Inhaler Devices Market, by Respiratory Care Centers, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Respiratory Inhaler Devices Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Respiratory Inhaler Devices Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 38 Global Respiratory Inhaler Devices Market, by patient, 2023-2030 (US$ Bn)
TABLE 39 Global Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 40 Global Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 41 Global Respiratory Inhaler Devices Market, by Region, 2017-2022 (US$ Bn)
TABLE 42 Global Respiratory Inhaler Devices Market, by Region, 2023-2030 (US$ Bn)
TABLE 43 North America Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 44 North America Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 45 North America Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 46 North America Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 47 North America Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 48 North America Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 49 North America Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 50 North America Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 51 North America Respiratory Inhaler Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 52 North America Respiratory Inhaler Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 53 United States Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 54 United States Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 55 United States Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 56 United States Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 57 United States Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 58 United States Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 59 United States Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 60 United States Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 61 Canada Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 62 Canada Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 63 Canada Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 64 Canada Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 65 Canada Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 66 Canada Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 67 Canada Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 68 Canada Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 69 Mexico Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 70 Mexico Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 71 Mexico Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 72 Mexico Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 73 Mexico Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 74 Mexico Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 75 Mexico Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 76 Mexico Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 77 Europe Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 78 Europe Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 79 Europe Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 80 Europe Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 81 Europe Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 82 Europe Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 83 Europe Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 84 Europe Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 85 Europe Respiratory Inhaler Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 86 Europe Respiratory Inhaler Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 87 Germany Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 88 Germany Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 89 Germany Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 90 Germany Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 91 Germany Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 92 Germany Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 93 Germany Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 94 Germany Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 95 France Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 96 France Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 97 France Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 98 France Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 99 France Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 100 France Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 101 France Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 102 France Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 103 United Kingdom Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 104 United Kingdom Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 105 United Kingdom Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 106 United Kingdom Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 107 United Kingdom Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 108 United Kingdom Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 109 United Kingdom Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 110 United Kingdom Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 111 Italy Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 112 Italy Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 113 Italy Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 114 Italy Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 115 Italy Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 116 Italy Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 117 Italy Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 118 Italy Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 119 Spain Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 120 Spain Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 121 Spain Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 122 Spain Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 123 Spain Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 124 Spain Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 125 Spain Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 126 Spain Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 127 Rest of Europe Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 128 Rest of Europe Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 129 Rest of Europe Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 130 Rest of Europe Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 131 Rest of Europe Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 132 Rest of Europe Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 133 Rest of Europe Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 134 Rest of Europe Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 135 Asia Pacific Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 136 Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 137 Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 138 Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 139 Asia Pacific Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 140 Asia Pacific Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 141 Asia Pacific Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 142 Asia Pacific Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 143 Asia Pacific Respiratory Inhaler Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 144 Asia Pacific Respiratory Inhaler Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 145 China Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 146 China Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 147 China Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 148 China Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 149 China Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 150 China Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 151 China Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 152 China Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 153 Japan Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 154 Japan Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 155 Japan Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 156 Japan Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 157 Japan Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 158 Japan Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 159 Japan Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 160 Japan Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 161 India Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 162 India Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 163 India Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 164 India Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 165 India Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 166 India Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 167 India Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 168 India Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 169 South Korea Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 170 South Korea Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 171 South Korea Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 172 South Korea Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 173 South Korea Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 174 South Korea Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 175 South Korea Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 176 South Korea Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 177 South-East Asia Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 178 South-East Asia Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 179 South-East Asia Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 180 South-East Asia Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 181 South-East Asia Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 182 South-East Asia Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 183 South-East Asia Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 184 South-East Asia Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 185 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 186 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 187 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 188 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 189 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 190 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 191 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 192 Rest of Asia Pacific Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 193 Latin America Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 194 Latin America Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 195 Latin America Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 196 Latin America Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 197 Latin America Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 198 Latin America Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 199 Latin America Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 200 Latin America Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 201 Latin America Respiratory Inhaler Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 202 Latin America Respiratory Inhaler Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 203 Brazil Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 204 Brazil Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 205 Brazil Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 206 Brazil Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 207 Brazil Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 208 Brazil Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 209 Brazil Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 210 Brazil Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 211 Argentina Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 212 Argentina Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 213 Argentina Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 214 Argentina Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 215 Argentina Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 216 Argentina Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 217 Argentina Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 218 Argentina Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 219 Rest of Latin America Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 220 Rest of Latin America Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 221 Rest of Latin America Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 222 Rest of Latin America Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 223 Rest of Latin America Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 224 Rest of Latin America Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 225 Rest of Latin America Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 226 Rest of Latin America Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 227 Middle East and Africa Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 228 Middle East and Africa Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 229 Middle East and Africa Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 230 Middle East and Africa Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 231 Middle East and Africa Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 232 Middle East and Africa Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 233 Middle East and Africa Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 234 Middle East and Africa Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 235 Middle East and Africa Respiratory Inhaler Devices Market, by Country, 2017-2022 (US$ Bn)
TABLE 236 Middle East and Africa Respiratory Inhaler Devices Market, by Country, 2023-2030 (US$ Bn)
TABLE 237 GCC Countries Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 238 GCC Countries Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 239 GCC Countries Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 240 GCC Countries Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 241 GCC Countries Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 242 GCC Countries Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 243 GCC Countries Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 244 GCC Countries Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 245 South Africa Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 246 South Africa Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 247 South Africa Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 248 South Africa Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 249 South Africa Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 250 South Africa Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 251 South Africa Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 252 South Africa Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)
TABLE 253 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 254 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 255 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Patient, 2017-2022 (US$ Bn)
TABLE 256 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Patient, 2023-2030 (US$ Bn)
TABLE 257 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Technology, 2017-2022 (US$ Bn)
TABLE 258 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Technology, 2023-2030 (US$ Bn)
TABLE 259 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Disease Indication, 2017-2022 (US$ Bn)
TABLE 260 Rest of Middle East and Africa Respiratory Inhaler Devices Market, by Disease Indication, 2023-2030 (US$ Bn)

 

Frequently Asked Questions

What is the current size of the global respiratory inhaler devices market?

The global respiratory inhaler devices market was valued at USD 35.2 Billion in 2022.

What is the expected growth rate of the respiratory inhaler devices market between 2023 and 2030?

The respiratory inhaler devices market is expected to grow at a CAGR of 5.20% between 2023 and 2030, reaching USD 50.19 Billion in 2030.

Which segment holds the leading market share regarding product type?

Metered dose inhalers are the leading segment by product type, holding around half of the share in value in 2022.

Which is the largest patient of respiratory inhaler devices worldwide?

The adult patient governs the highest share of the patient segment in respiratory inhaler devices worldwide

Which segment is expected to post the highest CAGR during the forecast period?

The asthma segment will post the highest CAGR during the forecast period.

Which region is fuelling the growth of the respiratory inhaler devices industry?

North America is fuelling the growth of the respiratory inhaler devices industry, with a nearly two-fifth share in 2022.

Who are the major players in the global respiratory inhaler devices market?

The top players include Adherium, AstraZeneca, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., GlaxoSmithKline plc, Propeller Health, Teva Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., 3M, Cipla Inc., Koninklijke Philips N.V., Merck & Co., Inc., Omron Healthcare, Inc., Cohero Health, Inc., PARI GmbH, Glenmark Pharmaceuticals Limited, Senzer Ltd, Novartis AG, HELTMAN Medikal A.S., and Mundipharma International and others

What is the major market driver of the respiratory inhaler devices industry?

The rise in the per capita income of people worldwide is the major market driver.

What are the major market restraints of the respiratory inhaler devices industry?

Increasing adoption of alternative therapies such as oral medication or subcutaneous injections is the major factor restraining the growth of the respiratory inhaler devices industry.

What are the major market opportunities of the Respiratory Inhaler Devices industry?

the increasing adoption of combination therapies for asthma is an opportunity for the respiratory inhaler devices industry.

Antiviral Drugs Market

Published:
Report ID: 40681

AI in Oncology Market

Published:
Report ID: 40668

Automated Liquid Handling Systems Market

Published:
Report ID: 40663

Non Infectious Macular Edema Treatment Market

Published:
Report ID: 7337

U.S. Medical Device Contract Manufacturing Market

Published:
Report ID: 40557

Endoscopes Market

Published:
Report ID: 40551

Animal Wound Care Market

Published:
Report ID: 40564

Adeno Associated Viral Vector Market

Published:
Report ID: 40601

AI Based Drug Discovery Market

Published:
Report ID: 40608

Intravitreal Injectable Market

Published:
Report ID: 7250

Pharmacogenomics Market

Published:
Report ID: 9486

Nosocomial Infection Treatment Market

Published:
Report ID: 14189

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN